MTOR and ovarian cancer: In high grade ovarian cancer, high expression of GGCT has been confirmed to correlate with poorer OS, and GGCT facilitates the progression of ovarian cancer by activating the PI3K/AKT/mTOR pathway (Li et al. 2018).